TY - JOUR
T1 - Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome
T2 - additional evidence for increased risk
AU - PTEN Study Group
AU - Schei-Andersen, Ane J.
AU - Witjes, Vera M.
AU - Vos, Janet R.
AU - Mensenkamp, Arjen R.
AU - van Altena, Anne
AU - Schieving, Jolanda
AU - Simons, Michiel
AU - Schuurs-Hoeijmakers, Janneke H.M.
AU - Nielsen, Maartje
AU - Leter, Edward M.
AU - Jongmans, Marjolijn C.J.
AU - de Jong, Mirjam
AU - van Ierland, Yvette
AU - van Hest, Liselotte P.
AU - Adank, Muriel A.
AU - Hoogerbrugge, Nicoline
N1 - © 2025. The Author(s).
PY - 2025/3/18
Y1 - 2025/3/18
N2 - Increased hereditary cancer risk is one of the hallmarks of PTEN Hamartoma Tumor Syndrome (PHTS) which is caused by a pathogenic germline variant in PTEN. Case reports and some cohort studies have described ovarian cancer (OC) in PHTS patients. Previously, we observed an enrichment of non-serous OC in PHTS compared to sporadic cases (3% vs 1%). However, ovarian cancer is currently not considered a PHTS-related cancer. The aim of this study was to describe five PHTS patients with a pathogenic germline variant in PTEN with non-serous OC. Three of the non-serous OCs were mucinous carcinomas (49, 51 and 52 years) and two were malignant germ cell tumors (8 and 15 years) and all were diagnosed before genetic testing and PHTS diagnosis. In addition to OC, the described patients developed other PHTS-related benign and malignant lesions. We provide further evidence that non-serous ovarian cancer, especially mucinous, endometrioid and malignant germ cell tumors should be further investigated as potential PHTS-related cancers.
AB - Increased hereditary cancer risk is one of the hallmarks of PTEN Hamartoma Tumor Syndrome (PHTS) which is caused by a pathogenic germline variant in PTEN. Case reports and some cohort studies have described ovarian cancer (OC) in PHTS patients. Previously, we observed an enrichment of non-serous OC in PHTS compared to sporadic cases (3% vs 1%). However, ovarian cancer is currently not considered a PHTS-related cancer. The aim of this study was to describe five PHTS patients with a pathogenic germline variant in PTEN with non-serous OC. Three of the non-serous OCs were mucinous carcinomas (49, 51 and 52 years) and two were malignant germ cell tumors (8 and 15 years) and all were diagnosed before genetic testing and PHTS diagnosis. In addition to OC, the described patients developed other PHTS-related benign and malignant lesions. We provide further evidence that non-serous ovarian cancer, especially mucinous, endometrioid and malignant germ cell tumors should be further investigated as potential PHTS-related cancers.
KW - Genetics
KW - Hereditary cancer
KW - Ovarian cancer
KW - PHTS
KW - PTEN
KW - Phenotype
KW - Neoplasms, Germ Cell and Embryonal/genetics
KW - Hamartoma Syndrome, Multiple/genetics
KW - Genetic Predisposition to Disease
KW - Adenocarcinoma, Mucinous/genetics
KW - Humans
KW - Middle Aged
KW - Ovarian Neoplasms/genetics
KW - PTEN Phosphohydrolase/genetics
KW - Germ-Line Mutation
KW - Adult
KW - Female
UR - https://www.scopus.com/pages/publications/105000819050
UR - https://www.mendeley.com/catalogue/2c84c51f-e692-31e9-a298-3531044326b8/
U2 - 10.1007/s10689-025-00453-z
DO - 10.1007/s10689-025-00453-z
M3 - Article
C2 - 40100464
AN - SCOPUS:105000819050
SN - 1389-9600
VL - 24
JO - Familial Cancer
JF - Familial Cancer
IS - 2
M1 - 28
ER -